CARBON NANOTUBE NANO-THERAPY COMPOSITES WITH PACLITAXEL
    7.
    发明申请
    CARBON NANOTUBE NANO-THERAPY COMPOSITES WITH PACLITAXEL 审中-公开
    碳纳米管纳米治疗复合材料与PACLITAXEL

    公开(公告)号:US20160095940A1

    公开(公告)日:2016-04-07

    申请号:US14963845

    申请日:2015-12-09

    摘要: In various embodiments a payload molecule or drug molecule delivery system is disclosed for delivering paclitaxel. The system comprises a plurality of functionalized discrete carbon nanotubes having specific properties. The composition can comprise a plurality of discrete carbon nanotubes that have at least a portion of the carbon nanotubes with a number average (ratio of number average contour length to end to end length) of greater than 1.1 and up to about 3. These discrete carbon nanotubes having the specified ratio of number average (tube contour length (TCL) to number average tube end-end length (TEE)) ratio are not only discrete (separated) from one another, but are also controlled in their alignment such that processability and mechanical strength properties are both enhanced. Utility of the molecular rebar composition includes, but is not limited to improved payload molecule delivery, such as drug delivery, into body of an animal, such as human.

    摘要翻译: 在各种实施方案中,公开了用于递送紫杉醇的有效载荷分子或药物分子递送系统。 该系统包括具有特定性质的多个功能化离散碳纳米管。 该组合物可以包含多个离散的碳纳米管,其具有大于1.1并且高达约3的数均分(数均轮廓长度与端到端长度之比)的碳纳米管的至少一部分。这些离散碳 具有规定的数均比(管轮廓长度(TCL)至数均管末端长度(TEE))比率的纳米管不仅彼此离散(分离),而且也被对准控制,使得加工性和 机械强度性能均得到提高。 分子钢筋组合物的实用性包括但不限于改进的有效载荷分子递送,例如药物递送到动物如人的体内。